Biosimilar Products—A Review of Past and Current Regulatory Approval Standards for Preclinical Safety Studies

A. Kimzey,K. Mease, B. Mounho-Zamora, M. Wood

Translational Medicine(2021)

Cited 0|Views2
No score
Key words
preclinical safety studies,current regulatory approval standards,products—a
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined